The aim of the present study was to investigate the role of neurotensin in the regulation of N T 1 receptors during postnatal development in the rat brain. Characterization of the ontogeny of neurotensin concentration and [ 
INTRODUCTION
Neurotensin, a 13 amino-acid neuropeptide, is heterogeneously distributed in the mammalian brain (Alexander et al., 1989) . In the central nervous system (CNS), neurotensin acts as a neurotransmitter and neuromodulator of several neuronal systems; in particular, neurotensin has been shown to play an important role in the modulation of dopamine transmission (Lambert et al., 1995) . Neurotensin is also involved in nociception, thermoregulation and modulation of neuroendocrine systems (for reviews, see Nemeroff and Kitabgi, 1992; Rostène and Alexander, 1997) .
Two types of neurotensin receptors, NT 1 and NT 2 , have been cloned and shown to belong t o the family of G protein-coupled receptors (Tanaka et al., 1990; Vita et al., 1993; Chalon et al., 1996; Mazella et al., 1996) . These two receptors are distinguished by their affinity for neurotensin and their capacity to bind levocabastine, a histamine H 1 receptor antagonist (Schotte et al., 1986) . The levocabastine-insensitive, high-affinity neurotensin receptor (NT 1 ) mediates most of the physiological functions ascribed to neurotensin. In contrast, only limited data are available concerning the functional role of the levocabastine-sensitive, lower-affinity neurotensin receptor (NT 2 ). Using an anti-sense strategy in mice, the N T 2 receptor was implicated in the analgesic effects induced by neurotensin (Dubuc et al., 1999) . A third neurotensin receptor (NT 3 ) was recently cloned from human brain (Mazella et al., 1998) ; it does not belong to the superfamily of G protein-coupled receptors, corresponds to the previously cloned gp95/sortilin and could be involved in intracellular trafficking.
Previous studies on the ontogeny of N T 1 receptors in the rat brain using autoradiography (Palacios et al., 1988) , binding experiments in brain homogenates (Schotte and Laduron, 1987) and in situ hybridization Lépée-Lorgeoux et al., 1999) , reported marked regional differences in their developmental profile. Thus, the cerebral cortex exhibits a high and transient expression of NT 1 receptors during the early postnatal period, which declines to reach adult levels by the third postnatal week, whereas other brain areas, including the midbrain, show a gradual increase in NT 1 receptor expression from late gestation to the second week of life.
Interestingly, neurotensin is also highly expressed in the brain at birth, followed by a dramatic decrease to adult levels during the second and third weeks of postnatal life (Hara et al., 1982; Sato et al., 1991; Bennett et al., 1998) .
The role of endogenous ligands in establishing the developmental pattern of expression of their corresponding receptors has been suggested for several neurotransmitter systems, including neuropeptides (Kudlacz et al., 1991; Hill et al., 1994; Sircar et al., 1996; Liu et al., 1998) .
However, the possible involvement of neurotensin in the regulation of N T 1 receptors during ontogeny has not been studied. In a recent series of experiments, we used the non-peptide antagonist of NT 1 receptors SR 48692 to investigate the role of endogenous neurotensin in the regulation of NT 1 receptors in the adult rat brain. We showed that chronic administration of SR 48692 induces an up-regulation of NT 1 receptor binding sites and mRNA expression, suggesting a tonic inhibitory control of neurotensin on N T 1 receptors in the mature brain (Azzi et al., 1994 (Azzi et al., , 1996 Najimi et al., 1998) .
The aim of the present study was to investigate the role of neurotensin in the regulation of N T 1 receptors during postnatal development in the rat brain. We first examined concomitantly the ontogeny of neurotensin content and N T 1 receptor expression, since previous studies examining separately either parameter rendered difficult their comparison at a given time point.
Second, we used primary cultures of embryonic neurons from rat cerebral cortex, the brain region with the highest expression of NT 1 receptors during early development, to investigate whether these receptors could be regulated by the agonist at an early developmental stage. The amount of N T 1 receptor mRNA transcripts in the cultures was measured by quantitative reverse transcription-polymerase chain reaction (RT-PCR). Finally, we studied the effects of in vivo blockade of neurotensinergic transmission during postnatal development in rat pups injected with the NT 1 receptor antagonist SR 48692. [ 125 I]neurotensin binding to N T 1 receptors was examined using brain homogenates and autoradiography, and NT 1 receptor mRNA expression was assessed by in situ hybridization histochemistry.
MATERIALS AND METHODS

Animals and treatments
Wistar rats bred in our laboratory were maintained on a 12-hour dark/light cycle and were given food and water ad libitum. To study the ontogeny of neurotensin and N T 1 receptor expression in the brain, rats were analyzed at different prenatal and postnatal ages (E15, E20, P0, P5, P10, P15, P21 and P30). The day of the vaginal plug was counted as E1 and the day of birth as P0. All experiments were performed in accordance with the European Communities Council Directive for the care and use of laboratory animals.
In order to examine the role of endogenous neurotensin in the developmental regulation of N T 1 receptors, rat pups received a daily subcutaneous (s.c.) injection of the non-peptide NT 1 receptor antagonist, SR 48692 Sanofi Recherche, Toulouse, France) , for different periods of time: P1-P5, P1-P9 or P1-P15 (n = six per group). SR 48692, administered at the dose of 1 mg/kg, was solubilized in Tween 20 and dissolved in sterile 0.9% NaCl solution. This dose of SR 48692 was chosen because it was previously shown to induce an up-regulation of N T 1 receptors in the adult rat (Azzi et al., 1996; Najimi et al., 1998) . Control pups were injected with vehicle (Tween 20 1% in NaCl 0.9%). In a separate group of animals, prenatal treatment with SR 48692 was started at E15; pregnant dams received a daily injection of the antagonist until the day of birth, after which pups were injected with SR 48692 from P1 to P9. In all experiments, rats were decapitated 24 h after the last injection.
Preparation of fetal brain cortical cultures and treatment with neurotensin agonist and/or antagonist
Cultures were prepared from the cerebral cortex of Wistar rat fetuses at E17 following the procedure previously described for cultures of hypothalamic neurons (Scarcériaux et al., 1996) .
The cerebral cortex was excised under sterile conditions and microscopic control, and cells were grown in serum-free medium consisting of a mixture of Dulbecco modified Eagle's medium and Ham-F12 (1vol/1vol, Gibco), 15 mM HEPES, NaHCO 3 as indicated by the manufacturer, 0.5 U/ml penicillin, 20 µg/ml streptomycin, 5 µg/ml insulin, 100 µg/ml human transferrin, 2.10 -8 M progesterone, 10 -12 M 17 β-estradiol, 1 µg/ml arachidonic acid, 0.5 µg/ml docosahexaenoic acid, 3.10 -8 M selenium, 10 -4 M putrescine and 0.5 mM glutamine. Cells were plated at a density of 400,000 cells per cm 2 in six-well plastic culture plates (Costar) previously coated with poly-Dlysine. Cultures were maintained in a moist atmosphere (95% air, 5% CO 2 ) at 37°C and medium was renewed after 5 days. Cytosine arabinoside (1 µM) was added from the first change onward t o prevent further glial proliferation. After 5 days of culture, neurons were incubated in the presence of the neurotensin agonist JMV 449 (Doulut et al., 1992; Neosystem) , 1 nM; the NT 1 receptor antagonist SR 48692, 1 µM; or both drugs. SR 48692 was dissolved in dimethyl sulfoxide (DMSO);
incubation of cortical neurons in the presence of DMSO (final concentration 0.1%) showed that the solvent alone had no effect on NT 1 receptor mRNA expression. After 48 h, the culture medium was removed and the cells were rinsed with ice-cold phosphate-buffered saline. Total RNA was extracted by the acid guanidium thiocyanate-phenol chloroform method (Chomczynski and Sacchi, 1987) , followed by ethanol precipitation.
Quantitative RT-PCR of NT 1 receptor mRNA
Internal standard preparation and quantitative RT-PCR were carried out as described (Souazé et al., 1997) . Briefly, a plasmid pNTR18 was constructed by inserting the entire coding sequence of rat NT 1 receptor cDNA (nt: -7 to 1301) into the SmaI/BamHI sites of p T7/T3α18. A 34-nucleotide deletion was created by removing the NCoI-NHeI fragment. A polyA (45) 
Radioimmunoassay of neurotensin
Brains were homogenized and sonicated in ice-cold 0.1 N HCl. Homogenates were boiled for 10 min and centrifuged at 10,000 g for 15 min at 4°C. Supernatants were separated and frozen at -20°C until use. The neurotensin radioimmunoassay was performed as described previously (Scarcériaux et al., 1995) , with a specific antibody directed against neurotensin diluted at 1:15,000
and [
125 I]neurotensin as the tracer.
Brain membrane preparation and binding assays
Whole brains (minus cerebellum) were homogenized in ice-cold 50 mM Tris-HCl buffer, pH 7.4, centrifuged at 60,000 g for 35 min at 4°C, resuspended in the same buffer and recentrifuged. The pellets were then resuspended in 50 mM Tris-HCl buffer containing 0.1% bovine serum albumin, 0.5 mM 1-10 orthophenantroline, 1 mM EDTA and 4 mg/ml bacitracin, in a final concentration of 10-15 mg protein/ml. Membrane preparations were aliquoted, frozen in liquid nitrogen and stored at -80°C. Binding experiments were performed as described previously (Azzi et al., 1994) .
Brain membrane homogenates, 0.1 mg protein/ml, were incubated at room temperature in a final volume of 300 µl in 50 mM Tris-HCl buffer containing 0.2% bovine serum albumin, 5 mM MgCl 2 , 0.5 mM 1-10 orthophenantroline, and 0.1 nM [
125 I]Tyr 3 -neurotensin. All experiments were conducted in the presence of 1 µM levocabastine (Janssen, Beerse, Belgium), which selectively inhibits neurotensin binding to N T 2 receptors (Schotte et al., 1986) . Non-specific binding was determined in the presence of 1 µM unlabeled neurotensin (Neosystem Laboratories, Strasbourg, France). After incubation for 30 min, bound and free ligands were separated by centrifugation at 12,000 g for 4 min at 4°C. The bound radioactivity in the pellet was determined with a γ counter.
Competition studies were conducted with a single concentration of [ analyzed with a non-linear regression program (Munson and Rodbard, 1980) . Ki values were calculated according to the Cheng and Prusoff (1973) (Betancur et al., 1998) . Additional sections were incubated with 1 µM unlabeled neurotensin, t o determine non-specific binding. After incubation, the sections were washed four times for 2 min each in 40 mM Tris-HCl buffer, pH 7.4, at 4°C, dipped in distilled water and dried.
Autoradiograms were generated by apposition of labeled sections to Hyperfilm ßmax (Amersham), for two or five days (6-and 16-day-old rats, respectively).
In situ hybridization histochemistry
In situ hybridization histochemistry of N T 1 receptor mRNA was performed as described (Lépée-Lorgeoux et al., 1999) , using four oligodeoxynucleotides complementary to nucleotides 128-169, 810-843, 1152-1184, 1375-1411 of the rat NT 1 receptor cDNA (Tanaka et al., 1990) . The oligonucleotides were 3' end-labeled with α-[
S]deoxyadenosine-5'-triphosphate (specific activity: >1000 Ci/mmol, Amersham), using terminal transferase (Boehringer Mannheim). The mixture containing the labeled probes (0.25 pmol/ml of each oligonucleotide; 10 7 cpm/ml) was diluted in hybridization solution (50% vol/vol formamide, 4 x SSC, 1% sarcosyl, 0.1 M potassium phosphate, pH 7.4, 250 µg/ml yeast tRNA, 250 µg/ml herring sperm DNA, 10% dextran sulfate, 1
x Denhardt's solution, 50 µg/ml polyA, 10 mM dithiothreitol), applied onto each slide and overlaid with a coverslip. Hybridization was allowed to proceed for 18 h at 42°C in humidified chambers. Film autoradiograms were obtained by apposition of radiolabeled sections to Hyperfilm ßmax for 20 or 30 days (6-and 16-day-old rats, respectively).
Quantitative analysis of autoradiograms
Quantitative optical density measurements of film autoradiograms were carried out using a computer-based image analysis system (HISTO-RAG, Biocom, Les Ulis, France). Optical densities of non-specific signal for in situ hybridization were determined in the corpus callosum, a brain area which does not contain NT 1 receptor mRNA, or in sections incubated with unlabeled neurotensin for [ are equivalent to the binding constants observed previously in the adult rat brain , whereas the number of receptors in the newborn brain is five-times higher than in the adult (Azzi et al., 1996) . 
Effect of chronic treatment with the antagonist SR 48692 on the ontogeny of NT 1 receptor expression
The contribution of endogenous neurotensin to the ontogeny of N T 1 receptors was studied in rat pups exposed to the NT 1 receptor antagonist SR 48692 during the third week of pregnancy or during early postnatal life. Daily SR 48692 treatment during pregnancy had no significant effect on litter size, mean body weight, and brain weight of the offspring (data not shown). Furthermore, there was no difference in the body and brain weight of pups treated postnatally with SR 48692 or vehicle.
Administration of the antagonist (1 mg/kg s.c.) was started at P1 and continued until P5, P 9 or P15, corresponding respectively to the period of increase, the peak or the whole period of high showing that neurotensin appears early in development and reaches maximal levels within the first postnatal week, decreasing thereafter (Hara et al., 1982; Bissette et al., 1984; Sato et al., 1991; Bennett et al., 1998) . The peak in [ 125 I]neurotensin receptor binding observed in brain homogenates during the second postnatal week corresponds mainly to the increased expression of NT 1 receptors in the cerebral cortex, the brain region with the highest expression of these receptors during the perinatal period (Palacios et al., 1988; Sato et al., 1992; Lépée-Lorgeoux et al., 1999) . Although only few neurotensin-containing neurons and fibers are present in the cerebral cortex, it has been suggested that neurotensin synthesized in other brain areas and/or present in the cerebrospinal fluid could exert a paracrine action on cortical receptors (Palacios et al., 1988; Sato et al., 1992) .
The ability of agonists to regulate the expression of their own receptors in vitro has been described for numerous receptor systems. Previous studies on the regulation of the N T 1 receptor in cell cultures showed that exposure to neurotensin results in receptor internalization, receptor down-regulation and regulation at the second messenger level (reviewed in Hermans and Maloteaux, 1998) . In order to investigate whether cortical NT 1 receptors could be regulated by the agonist at an early developmental stage, we studied the effect of a peptidase-resistant neurotensin agonist, JMV 449, on NT 1 receptor mRNA expression in primary cultures of fetal rat cerebral cortex neurons. Exposure of cortical neurons to JMV 449 for 48 h induced a significant decrease in NT 1 receptor mRNA, and this effect was abolished by the antagonist SR 48692. These results are in agreement with our previous studies on hypothalamic neuronal cultures, demonstrating that release of endogenous neurotensin induced by dexamethasone and forskolin down-regulates NT 1 receptor mRNA (Scarcériaux et al., 1996) . These data suggest that N T 1 receptors in the developing neocortex and hypothalamus can be regulated by the agonist, despite inherent differences in the maturational profile of N T 1 receptors in these two brain regions (Palacios et al., 1988; Sato et al., 1992) . In addition, these findings illustrate the ability of SR (Azzi et al., 1994 (Azzi et al., , 1996 . Thus, whereas endogenous neurotensin appears to exert a tonic inhibitory control on NT 1 receptors in the mature CNS, the results of the present study indicate that it does not play a major role in establishing the developmental profile of N T 1 receptors during the early postnatal period.
The lack of effect of SR 48692 is not due to undeveloped intracellular pathways of N T 1 receptors transiently expressed in the brain of fetal and infant rats, since NT 1 receptor gene expression in primary cell cultures prepared from E17 cerebral cortex was down-regulated after agonist-induced receptor activation. In addition, the differential effect of SR 48692 on the regulation of NT 1 receptors in the immature and adult rat brain can not be ascribed to different binding properties of these receptors, because NT 1 receptors in five-day-old rat brain have the same affinity for SR 48692 and neurotensin as NT 1 receptors present in the adult Azzi et al., 1996) . Hence, these findings suggest that NT 1 receptors expressed during the perinatal period represent functional receptors having the same ligand affinity as NT 1 receptors in the adult and may thus be involved in neuronal signaling.
In the neocortex, NT 1 receptors are abundantly expressed in the molecular layer, the cortical plate and the developing cortical layer VI during late gestation and the first postnatal week, followed by a dramatic decrease to the low levels seen in the adult at the end of the third postnatal week (Palacios et al., 1988) . The transient expression of N T 1 receptors in the cerebral cortex could be related to the reorganization of cortical neurons during postnatal development, including neuronal death, which is a prominent feature of the normal development of the neocortex (Ferrer et al., 1992) . Moreover, the formation of the pattern of cortical connectivity, the regression of and trophic effects in normal and cancer cells in the intestine, liver, pancreas, lung and prostate (Evers et al., 1992; Hasegawa et al., 1994; Sehgal et al., 1994) . The proliferative effect of neurotensin on intestinal cells is mediated by N T 1 receptors (Ehlers et al. 1998) . In addition, neurotensin has been shown to stimulate proliferation of astrocytic cell lines (Camby et al., 1996) . It is noteworthy that the regionally specific and transient appearance of receptors during brain development has been reported for other neurotransmitters and peptides, including cholecystokinin, substance P, and vasopressin (Parnavelas and Cavanagh, 1988; Pélaprat et al., 1988; Tribollet et al., 1991; Zhang and Harlan, 1994; Taoka et al., 1996) , thus supporting the role of neurotransmitters and peptides as growth regulatory signals during maturation of the CNS (Lauder, 1993) .
Other brain areas, including the substantia nigra and ventral tegmental area, show a developmental pattern of NT 1 receptors radically different from the one observed in the neocortex, characterized by a gradual increase during the postnatal period (Palacios et al., 1988; Sato et al., 1992; Lépée-Lorgeoux et al., 1999) . These regions are also characterized by the presence of neurotensin terminals at birth and in the adult , therefore suggesting the possible regulation of N T 1 receptors in the developing brain following the HAL author manuscript inserm-00126155, version 1 administration of SR 48692, as shown in the adult (Azzi et al., 1994 (Azzi et al., , 1996 . However, as mentioned above, chronic blockade of N T 1 receptors during fetal and postnatal development did not affect the expression of receptors in the midbrain, suggesting that during this period, peptide release and connection formation are probably not sufficient for the regulation of N T 1 receptors by the endogenous ligand.
Early exposure of developing postsynaptic receptors to the appropriate agonist has been suggested to be important for establishing the ontogenetic pattern of several receptor systems.
For instance, postnatal treatment with a vasoactive intestinal polypeptide (VIP) antagonist increases expression of VIP receptors in the rat brain (Hill et al., 1994) . Furthermore, prenatal or postnatal exposure to GABA(A) or NMDA receptor antagonist selectively decrease the expression of certain receptor subunits in the developing brain (Sircar et al., 1996; Liu et al., 1998) . However, lack of agonist involvement in receptor ontogeny has also been described for some other members of the family of G protein-coupled receptors. Thus, prenatal administration of the β-adrenergic antagonist propranolol does not modify the expression of its receptors in the newborn rat brain (Kudlacz et al., 1991; Speiser et al., 1991) . Moreover, using the knockout approach, it was recently shown that deletion of the oxytocin gene does not alter the expression of oxytocin receptors in the CNS (Nishimori et al., 1996) . Similarly, mice unable to synthesize 181.8 ± 13.1 190.4 ± 6.6 P1-P15 67.2 ± 3.6 68.4 ± 5.5
Rat pups were injected daily with the neurotensin NT 1 receptor antagonist SR 48692 (1 mg/kg s.c.) or vehicle for different lengths of time starting at postnatal day 1 (P1). In another group, exposure to SR 48692 was started during the prenatal period, by daily administration of the antagonist to pregnant females from gestational day 15 (E15). Binding of [ 
